"Lipoproteins, IDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mixture of very-low-density lipoproteins (VLDL), particularly the triglyceride-poor VLDL, with slow diffuse electrophoretic mobilities in the beta and alpha2 regions which are similar to that of beta-lipoproteins (LDL) or alpha-lipoproteins (HDL). They can be intermediate (remnant) lipoproteins in the de-lipidation process, or remnants of mutant CHYLOMICRONS and VERY-LOW-DENSITY LIPOPROTEINS which cannot be metabolized completely as seen in FAMILIAL DYSBETALIPOPROTEINEMIA.
MeSH Number(s)
D10.532.473
D12.776.521.514
Concept/Terms
Lipoproteins, IDL- Lipoproteins, IDL
- IDL Lipoproteins
- Lipoproteins, Intermediate Density
- Lipoprotein, IDL
- IDL Lipoprotein
- Intermediate Density Lipoproteins
- Intermediate-Density Lipoproteins
- Lipoproteins, Intermediate-Density
alpha2-Very-Low-Density Lipoproteins- alpha2-Very-Low-Density Lipoproteins
- Lipoproteins, alpha2-Very-Low-Density
- alpha2 Very Low Density Lipoproteins
- alpha2-VLDL Lipoprotein
- Lipoprotein, alpha2-VLDL
- alpha2 VLDL Lipoprotein
- alpha2-VLDL
- alpha2 VLDL
Below are MeSH descriptors whose meaning is more general than "Lipoproteins, IDL".
Below are MeSH descriptors whose meaning is more specific than "Lipoproteins, IDL".
This graph shows the total number of publications written about "Lipoproteins, IDL" by people in Harvard Catalyst Profiles by year, and whether "Lipoproteins, IDL" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
Below are the most recent publications written about "Lipoproteins, IDL" by people in Profiles.
-
Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- mice. Nat Commun. 2020 08 14; 11(1):4084.
-
A comprehensive study of metabolite genetics reveals strong pleiotropy and heterogeneity across time and context. Nat Commun. 2019 10 21; 10(1):4788.
-
Chronic consumption of an inositol-enriched carob extract improves postprandial glycaemia and insulin sensitivity in healthy subjects: A randomized controlled trial. Clin Nutr. 2016 06; 35(3):600-7.
-
Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. Atherosclerosis. 2015 Aug; 241(2):326-33.
-
Trafficking of endogenous smooth muscle cell cholesterol: a role for serum amyloid A and interleukin-1ß. Arterioscler Thromb Vasc Biol. 2012 Nov; 32(11):2741-50.
-
Complexities of plasma apolipoprotein C-III metabolism. J Lipid Res. 2011 Jun; 52(6):1067-1070.
-
Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes. 2010 May; 59(5):1153-60.
-
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia. J Lipid Res. 2010 Jun; 51(6):1524-34.
-
Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):239-45.
-
Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. Biochem Biophys Res Commun. 2009 Jan 16; 378(3):433-8.